Tobacco induced diseases, 2020-12, Vol.18 (December), p.1-2
2020
Details
- Autor(en) / Beteiligte
- Titel
- FCTC Article 2.1 and the next horizon in tobacco policy: Phasing out commercial sales
- Ist Teil von
- Tobacco induced diseases, 2020-12, Vol.18 (December), p.1-2
- Ort / Verlag
- Heraklion: European Publishing
- Erscheinungsjahr
- 2020
- Link zum Volltext
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Beschreibungen/Notizen
- On Monday 9 November, Action on Smoking and Health (US), the Menzies School of Health Research (Australia), and Health Funds for a Smoke-free Netherlands, held a panel on the largely overlooked FCTC Article 2.1, which calls on governments to go beyond the minimum obligations specified in the treaty. Perception of Lung Cancer Risk: Impact of Smoking Status and Nicotine Dependence. Chris Bostic 1; Marita Hefler 2; Guy Muller 3; Mary Assunta 4 1Action on Smoking and Health, Washington, United States 2Menzies School of Health Research, Charles Darwin University, Darwin, Australia 3Dutch Cancer Society, Amsterdam, The Netherlands 4Global Centre for Good Governance in Tobacco Control, Bangkok, Thailand
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1617-9625, 2070-7266eISSN: 1617-9625DOI: 10.18332/tid/130673Titel-ID: cdi_doaj_primary_oai_doaj_org_article_ca3bcf42fefd450198f33a00211a1862
- Format
- –
- Schlagworte
- COVID-19, Drug dependence, fctc, Health risks, Lung cancer, Medical research, Nicotine, Pandemics, Sales, Smoking, Tobacco, tobacco endgame, Tobacco industry, tobacco policy, tobacco sales